Traumen Life Sciences Private Limited

Traumen Life Sciences Private Limited - pharma in Virar West, Maharashtra, India. FY 2026 financials & compliance.
CIN U24233MH2015PTC264497 Incorporated 15 May 2015 ROC Mumbai HQ Virar West, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹67.55 Lakh
▲ 43% YoY
Net profit · FY 2022
₹1.05 Lakh
Net margin 1.6%
EBITDA · FY 2022
₹1.6 Lakh
EBITDA margin 2.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹7.8 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings

About Traumen Life Sciences Private Limited

Data last updated:

Traumen Life Sciences Private Limited is a private limited company based in Virar West, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 May 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2015PTC264497. Its GSTIN is 27AAFCT3521P3ZX (Maharashtra). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Saurabh Kumar Srivastava and Narendra Bhojesing Jamadar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 26 Giriraj Complex Gokul Township, Virar West, Maharashtra, India – 401303.

As per the financials filed for FY 2022, the company reported a revenue of ₹67.55 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Lakh (net margin 1.6%) and EBITDA of ₹1.6 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.

The company is associated with 1 brand: Traumen Life Sciences. As per MCA filings, the company has open charges of ₹7.8 Lakh on record.

The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website traumenlifescience.com.

Company Details of Traumen Life Sciences Private Limited
CIN U24233MH2015PTC264497
Registration Number 264497
Incorporation Date 15 May 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Non-Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Shop No. 26 Giriraj Complex Gokul Township, Virar West, Maharashtra, India – 401303
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Traumen Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Traumen Life Sciences Private Limited report

Financials, compliance, directors, charges, ownership and filings for Traumen Life Sciences Private Limited in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Business Activity of Traumen Life Sciences Private Limited

The main business activity of Traumen Life Sciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GWholesale and retail trade; repair of motor vehicles and motorcycles47Retail trade, except of motor vehicles and motorcyclesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Traumen Life Sciences Private Limited FY 2025 filings available

Traumen Life Sciences Private Limited reported revenue of ₹67.55 Lakh (up 43% YoY) for FY 2022.

Revenue · FY 2022
₹67.55 Lakh ▲ 43%
Net profit · FY 2022
₹1.05 Lakh margin 1.6%
EBITDA · FY 2022
₹1.6 Lakh margin 2.4%

Compounded Annual Growth Rate (CAGR) of Traumen Life Sciences Private Limited

Revenue CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▼ 10%
5 years · compounded
▲ 88%

Revenue has grown at a compounded annual rate (CAGR) of 16% over three years, including 43% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Traumen Life Sciences Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations₹67.55 Lakh••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.6 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.05 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Traumen Life Sciences Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin2.4%••••••••••••••••
Net Profit Margin1.6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Traumen Life Sciences are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Traumen Life Sciences Private Limited

Traumen Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Orisun Lifesciences Private Limited₹67.82 Lakh (FY 2024)••••••••94.0%••••Panvel, Maharashtra, India
Be Pharmaceuticals Private Limited₹67.68 Lakh (FY 2025)••••••••-12.0%••••Hyderabad, Telangana, India
Cassel Research Laboratories Private Limited₹67.67 Lakh (FY 2023)••••••••180.0%••••Chennai, Tamil Nadu, India
Vizhli Pharma Private Limited₹67.65 Lakh (FY 2025)••••••••0.0%••••Namakkal, Tamil Nadu, India
Iaan Healthcare Private Limited₹67.56 Lakh (FY 2025)••••••••-4.0%••••Panchkula, Haryana, India
Traumen Life Sciences Private Limited this company₹67.55 Lakh (FY 2022)••••••••43.0%••••Virar West, Maharashtra, India
Medox Remedies Private Limited₹67.35 Lakh (FY 2022)••••••••30.0%••••New Delhi, Delhi, India
Oricare Pharma Private Limited₹67.23 Lakh (FY 2023)••••••••0.0%••••Ahmedabad, Gujarat, India
Cinstruments Private Limited₹67.15 Lakh (FY 2025)••••••••124.0%••••Hyderabad, Telangana, India
Well Rise Pharma Private Limited₹67.15 Lakh (FY 2024)••••••••55.0%••••Delhi, India
Sriramchem Laboratories Private Limited₹67.12 Lakh (FY 2024)••••••••16.0%••••Mysore, Karnataka, India

Peers are the five companies nearest above and the five nearest below Traumen Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Board of Directors of Traumen Life Sciences Private Limited

Traumen Life Sciences has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Saurabh Kumar SrivastavaDirector15 May 201511 Years 4 MonthsCurrent
Narendra Bhojesing JamadarDirector15 May 201511 Years 4 MonthsCurrent
Chetan Kumar VermaDirector15 May 201511 Years 4 MonthsCurrent

Ownership and Shareholding of Traumen Life Sciences Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Traumen Life Sciences Private Limited

Open charges
₹7.8 Lakh
Satisfied charges
None
Breakdown by lending institutions
Idbi Bank Limited₹0.08 Cr
Latest charge details
DateLenderAmountStatus
09 Sep 2022Idbi Bank Limited₹7.8 LakhOpen

Total charge records: 1 View all charges

Associated Brands with Traumen Life Sciences Private Limited

Traumen Life Sciences operates one associated brand: Traumen Life Sciences. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing and marketing of Allopathic medicines with customized packaging services.traumenlifescience.com

Employees and EPFO Compliance at Traumen Life Sciences Private Limited

Employment history and EPFO contributions of people linked to Traumen Life Sciences.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Traumen Life Sciences Private Limited

Traumen Life Sciences Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Chetan Kumar Verma was appointed as Director on 15 May 2015.

AGM
Traumen Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Traumen Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Idbi Bank Limited amounted to Rs. 7.80 Lakh with Charge ID 100623634 was registered on 09 Sep 2022.
Appointed
Chetan Kumar Verma was appointed as Director.
Appointed
Narendra Bhojesing Jamadar was appointed as Director.
Appointed
Saurabh Kumar Srivastava was appointed as Director.
Incorporation
15 May 2015
Traumen Life Sciences Private Limited was registered on 15 May 2015 with Roc Mumbai & aged 11 years 4 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Traumen Life Sciences Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Traumen Life Sciences Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Traumen Life Sciences Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Traumen Life Sciences Private Limited

Traumen Life Sciences has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AAFCT3521P3ZXMaharashtraActive16 Aug 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Traumen Life Sciences Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Traumen Life Sciences Private Limited

Traumen Life Sciences is an active private limited company based in Virar West, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 May 2015 (11+ years old) and is registered under CIN U24233MH2015PTC264497.

Traumen Life Sciences reported revenue of ₹67.55 Lakh for FY 2022 (up 43% YoY).

Traumen Life Sciences has 3 current directors:

Traumen Life Sciences reported a net profit of ₹1.05 Lakh (net margin 1.6%) and EBITDA of ₹1.6 Lakh (EBITDA margin 2.4%) for FY 2022, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Traumen Life Sciences is 16% over three years. In the latest year (FY 2022) revenue rose 43%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Traumen Life Sciences is 27AAFCT3521P3ZX, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Traumen Life Sciences is U24233MH2015PTC264497. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Traumen Life Sciences was incorporated on 15 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Traumen Life Sciences by revenue are Orisun Lifesciences Private Limited, Be Pharmaceuticals Private Limited, Cassel Research Laboratories Private Limited, Vizhli Pharma Private Limited, Iaan Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).

Chetan Kumar Verma was appointed as Director on 15 May 2015. Narendra Bhojesing Jamadar was appointed as Director on 15 May 2015. Saurabh Kumar Srivastava was appointed as Director on 15 May 2015.

Traumen Life Sciences can be reached through the website traumenlifescience.com. Its registered office is in Virar West, Maharashtra, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available